Keywords: fda, issues, refusal-to-file, letter, imclone, cancer, drug

FDA issues a refusal-to-file letter to ImClone for cancer drug Erbitux

Article | 07 January 2002

Print This

The US Food and Drug Administration has issued a refusal-to-file letterto ImClone Systems relating to its Biologics License Application for ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in